Physician profile
Jonathan Needler
NPI 1912155490
$6,686.30
in general payments reported to CMS, 2019-2025
23 companies · $2,192 in 2025
The $2,192 reported for 2025 was more than what 96% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $670 · 2023: $1,641 · 2024: $2,058 · 2025: $2,192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,724 · Travel and Lodging: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,724.10 |
| Travel and Lodging | $167.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,789.36 | 2022-2025 | Inspire |
| Aerin Medical INC. | $662.75 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $604.24 | 2022-2025 | Breztri, Airsupra |
| Medtronic, INC. | $452.39 | 2023-2024 | Propel, Nuvent |
| Amgen INC. | $378.10 | 2025 | Krystexxa |
| Regeneron Healthcare Solutions, INC. | $276.53 | 2023-2025 | Dupixent |
| Genzyme Corporation | $242.80 | 2022-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $146.44 | 2025 | Lumryz |
| Acclarent, INC | $131.04 | 2021-2023 | Relieva Spinplus |
| Teva Pharmaceuticals USA, INC. | $130.81 | 2023 | Austedo |
| Janssen Pharmaceuticals, INC | $128.42 | 2024 | Xarelto |
| Mannkind Corporation | $109.14 | 2022 | |
| Intersect Ent, INC. | $104.40 | 2021 | |
| Stryker Corporation | $101.24 | 2022-2024 | Scopis Ent |
| Nevro Corp. | $97.26 | 2023 | Senza |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $76.08 | 2025 | Lifevest |
| Scpharmaceuticals INC. | $75.38 | 2024 | |
| Philips North America LLC | $69.65 | 2023 | |
| Cochlear Americas | $30.59 | 2025 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Integra Lifesciences Corporation | $22.09 | 2024 | Acclarent Aera |
| Smith+Nephew, INC. | $21.39 | 2025 | Halo, Ent Sinus, Coblation |
| Ars Pharmaceuticals Operations, INC. | $21.29 | 2025 | Neffy |
| Hikma Pharmaceuticals USA | $14.91 | 2023 | Ryaltris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Needler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.